Form 8-K - Current report:
SEC Accession No. 0001558370-22-014596
Filing Date
2022-09-23
Accepted
2022-09-23 16:05:25
Documents
27
Period of Report
2022-09-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mrns-20220921x8k.htm   iXBRL 8-K 46771
2 EX-10.1 mrns-20220921xex10d1.htm EX-10.1 46368
3 EX-99.1 mrns-20220921xex99d1.htm EX-99.1 19634
4 GRAPHIC mrns-20220921xex99d1001.jpg GRAPHIC 8374
5 GRAPHIC mrns-20220921xex10d1010.jpg GRAPHIC 134928
6 GRAPHIC mrns-20220921xex10d1004.jpg GRAPHIC 148240
7 GRAPHIC mrns-20220921xex10d1007.jpg GRAPHIC 166517
8 GRAPHIC mrns-20220921xex10d1008.jpg GRAPHIC 151799
9 GRAPHIC mrns-20220921xex10d1011.jpg GRAPHIC 120020
10 GRAPHIC mrns-20220921xex10d1005.jpg GRAPHIC 117217
11 GRAPHIC mrns-20220921xex10d1001.jpg GRAPHIC 145630
12 GRAPHIC mrns-20220921xex10d1002.jpg GRAPHIC 72424
13 GRAPHIC mrns-20220921xex10d1009.jpg GRAPHIC 156172
14 GRAPHIC mrns-20220921xex10d1012.jpg GRAPHIC 30250
15 GRAPHIC mrns-20220921xex10d1003.jpg GRAPHIC 130047
16 GRAPHIC mrns-20220921xex10d1006.jpg GRAPHIC 155796
  Complete submission text file 0001558370-22-014596.txt   2377858

Data Files

Seq Description Document Type Size
17 EX-101.SCH mrns-20220921.xsd EX-101.SCH 3117
18 EX-101.LAB mrns-20220921_lab.xml EX-101.LAB 16590
19 EX-101.PRE mrns-20220921_pre.xml EX-101.PRE 10712
21 EXTRACTED XBRL INSTANCE DOCUMENT mrns-20220921x8k_htm.xml XML 5063
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS, INC. (Filer) CIK: 0001267813 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36576 | Film No.: 221262364
SIC: 2834 Pharmaceutical Preparations